MTP1.15 A 3.5-year study of ARTISS incisional hernia repair at a single UK Centre

Le résumé fourni par la source

Abstract Aim To determine retrospectively whether ARTISS fibrin sealant decreased the incidence of postoperative seroma formation in incisional hernia repair. Methods Review of electronic patient records for all patients who underwent ARTISS fibrin sealant incisional hernia repair due to previous midline laparotomies between January 2021 and July 2024. All patients had a Reevs-Stoppa incisional hernia repair with composite mesh, which was sutured in place with 2/0 prolene. Recorded outcomes included seroma formation and length of hospital stay. Results 38 patients were analysed in the study. The patients’ mean age was 53 years (range 37-69), and 23 patients were male. All the patients were non-smokers, and the cohort’s mean BMI was 27 (range BMI <35). There were no postoperative complications, including seroma formation and no ARTISS adverse effects. The cohort’s average length of hospital stay was 4 days (range 3-6). All patients had a routine outpatient follow-up at 8-10 weeks post-surgery. There was no re-operation within 30 days or additional outpatient department visits. Conclusions This study enabled assessment of collecting necessary data and provided insight into incisional hernia repair outcomes via ARTISS fibrin sealant within a 3.5-year period at a single UK centre. ARTISS fibrin sealant is an effective strategy to help prevent post-operative seroma formation in patients with incisional hernias.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.